Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Diclofenac is associated with a reduced incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis: results from a danish cohort study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Rationale for and Development of the Pancreatic Quantitative Sensory Testing Consortium to Study Pain in Chronic Pancreatitis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Modified Marshall Score Predicts Mortality in Patients With Walled-off Pancreatic Necrosis Treated in an Intensive Care Unit

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Fungal Infections in Patients With Walled-off Pancreatic Necrosis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Corrigendum to "Large Incisional Hernias Increase in Size" [Journal of Surgical Research 2019; 244: 160-165.]

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

  2. SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Sex-Dependent Shared and Nonshared Genetic Architecture Across Mood and Psychotic Disorders

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Impact of the COVID-19 pandemic on the management of colorectal cancer in Denmark

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

OBJECTIVE: The aim of this study was to assess the clinical effect of diclofenac administered as a single dose for the prevention of postprocedure pancreatitis in a consecutive series of patients who had undergone endoscopic retrograde cholangiopancreatography (ERCP).

METHODS: Patients with a native papilla Vateri subjected to ERCP during 2010 (control group, n = 218) and 2012 (diclofenac group, n = 182) were included. Patients with a history of chronic pancreatitis or recent acute pancreatitis were excluded. From January 2012, a rectal suppository containing 100 mg of diclofenac was administered immediately after endoscopy in all patients. The primary outcome of post-ERCP pancreatitis was assessed retrospectively by reviewing the patients' charts.

RESULTS: The overall incidence of post-ERCP pancreatitis was 32 (14.7%) of the 218 patients in the control group and 9 (4.9%) of the 182 patients in the diclofenac group (P = 0.002). Moderate to severe pancreatitis occurred in 22 (10.1%) of the 218 patients in the control group versus 8 (4.4%) of the 182 patients in the diclofenac group (P = 0.036).

CONCLUSIONS: This controlled cohort study suggests that the implementation of a single dose of 100 mg of diclofenac rectally administered significantly reduces the incidence of post-ERCP pancreatitis in an unselected material of patients with native papilla.

OriginalsprogEngelsk
TidsskriftPancreas
Vol/bind43
Udgave nummer8
Sider (fra-til)1286-90
Antal sider5
ISSN0885-3177
DOI
StatusUdgivet - nov. 2014

ID: 44661170